Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1185 results about "Antimicrobial peptides" patented technology

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.

Targeted antimicrobial moieties

This invention provides novel targeted antimicrobial compositions. In various embodiments chimeric moieties are provided comprising an antimicrobial peptide attached to a peptide targeting moiety that binds a bacterial strain or species.
Owner:C3 JIAN +1

Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides

Antimicrobial peptides enable an alternate approach to developing antimicrobial coatings due to their targeting of the membranes of the bacteria. High specific activity is achieved by orienting the peptides so that the antimicrobial ends of the peptides maximally contact the bacteria. In one embodiment, one end of the peptide is covalently attached directly to the substrate. In another embodiment, the peptides are immobilized on the substrate using a coupling agent or tether. Non-covalent methods include coating the peptide onto the substrate or physiochemically immobilizing the peptides on the substrate using highly specific interactions, such as the biotin / avidin or streptavidin system. The compositions are substantially non-leaching, antifouling, and non-hemolytic. The immobilized peptides retain sufficient flexibility and mobility to interact with and de endocytosed by the bacteria, viruses, and / or fungi upon exposure. Immobilizing the peptides to the substrate reduces concerns regarding toxicity of the peptides and the development of antimicrobial resistance, while presenting substantially all of the peptide at the site of action at the surface of the substrate.
Owner:MASSACHUSETTS INST OF TECH

Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant

InactiveUS6891085B2Improve the immunityImprove plant disease resistanceBiocideFungiMicroorganismAntimicrobial peptides
The methods and compositions of the present invention find use in impacting microbial pathogens and in enhancing disease resistance to pathogens, particularly by plants. The compositions of the invention include nucleic acid molecules encoding Fus6 polypeptides derived from Agrotis ipsilon that possess antimicrobial properties, particularly fungicidal properties. Further provided are plant cells plants, and seed thereof, transformed with the nucleic acid molecules of the invention so as to confer disease resistance on the plant.
Owner:EI DU PONT DE NEMOURS & CO +1

Selectively targeted antimicrobial peptides and the use thereof

The present invention relates to targeting peptides capable of specifically binding to microbial organisms (e.g., P. aeruginosa or S. mutans), antimicrobial peptides having antimicrobial activities, and specifically / selectively targeted antimicrobial peptides (STAMPs). In addition, the present invention provides methods of selectively killing or inhibiting microbial organisms by using the peptides or compositions provided by the present invention.
Owner:C3 JIAN +1

Method for preparing health-benefiting fermented soybean meal

The invention relates to a method for preparing health-benefiting fermented soybean meal enriched in small peptides, gamma-aminobutyric acid (GABA), reducing sugar, lactobacillus plantarum and antimicrobial peptide. By utilizing strains of aspergillus oryzae, saccharomyces cerevisiae, bacillus subtilis and lactobacillus plantarum, the small peptides, free amino acids, reducing sugar, GABA and high viable count content in the lactobacillus plantarum in the health-benefiting fermented soybean meal are obtained through the two-stage solid state fermentation method, the small peptides account for 8.01-18 percent, the free amino acids has the content of 80-300mg / g, the reducing sugar reaches 20-80mg / g, the GABA reaches 0.317-0.5mg / g, the viable count content in the lactobacillus plantarum is 2-6.5*1010cfu / g, the antibacterial titer of antimicrobial peptides is 2.0*103-7.0*104 IU / g, and the yield of the health-benefiting fermented soybean meal is 82.03-90 percent. According to the process, the nutrient effect of the soybean meal can be improved, the prepared fermented soybean meal has the antibacterial effect, partial antibiotics can be replaced, the fermented soybean meal is conveniently preserved and saved, the process is simple and feasible, and the fermented soybean meal is green and environment-friendly and has application significance and wide prospect in the feed industry and breeding industry.
Owner:ZHEJIANG UNIV OF TECH

Trophic factor combinations for nervous system treatment

The present invention relates to a composition including an effective amount of at least one of an antimicrobial peptide and a substance having an antimicrobial peptide effect and an effective amount of a neurotrophin. The composition can also include an effective amount of at least one of a growth factor and a neuropeptide. The present invention also relates a method of treating an injury to a nervous system of an animal that includes the steps of identifying the injury to the nervous system and applying to the injury an effective amount of at least one of antimicrobial peptide and a substance having an antimicrobial peptide effect. The method can also include applying an effective amount of one or more trophic factors selected from the group consisting of a growth factor, a neurotrophin, and a neuropeptide to the injury.
Owner:WISCONSIN ALUMNI RES FOUND

Modified alpha-MSH peptides and derivatives thereof

Novel peptides with antimicrobial activity are disclosed. The novel peptides are octomeric peptides modified from alpha-MSH. The modified alpha-MSH antimicrobial peptides disclosed herein may have enhanced activity against microbes over alpha-MSH due to modifications in peptide sequence and chirality of amino acids. Due an identified mechanism of action for antimicrobial activity in which cAMP accumulates in the microbial cell, it may be that microbes will not generate resistance to these modified alpha-MSH antimicrobial peptides.
Owner:ZENGEN

Anti-stress health compound feed for jewfish

The invention discloses an anti-stress health compound feed for jewfish. The feed consists of an animal protein source, a plant protein source, a fat source raw material, a sugar source raw material, composite vitamin, composite mineral salt, hepatinica, a Chinese herbal medicine compound preparation, probiotic powder, a composite immunopotentiator, antimicrobial peptide, an acidifying agent and a premixed compound additive, wherein the animal protein source comprises one or more of fish meal, euphausiid meal and chicken meat meal; the plant protein source comprises one or more of seaweed meal, fermented soybean meal, soy protein concentrate and corn protein powder; the fat source comprises one or more of soybean oil, fish oil and phosphatide oil. The feed disclosed by the invention has the characteristics of being rapid in growth, low in food coefficient, good in stability in water, rapid to eat, convenient to use, low in feeding cost, resistant to stress, healthy and the like.
Owner:珠海海龙生物科技有限公司

Virus derived antimicrobial peptides

InactiveUS6887847B2Lowering molar concentration requiredMinimal toxicityAntibacterial agentsBiocideBacteroidesLytic peptide
The invention is directed to peptides having antimicrobial activity (antimicrobial peptides). The antimicrobial peptides of the present invention are analogs of the Lentivirus Lytic Peptide 1 (LLP1) amino acid sequence. The invention is further directed to peptides referred to as the Lytic Base Unit (LBU) peptides derived from the LLP1 analogs, also having antimicrobial activity. In addition, the present invention is also directed to methods of using the peptides in a variety of contexts, including the treatment or prevention of infectious diseases. The antimicrobial LLP1 analog peptides and the LBU peptides (collectively eLLPs) may be highly active under high salt conditions and in biologic fluids. In addition, the eLLPs are effective when presented either in soluble form, or when attached to a solid surface. Furthermore, the peptides of the present invention are selectively active against a wide variety of bacterial pathogens and exhibit minimal toxicity to eukaryotic cells in vitro and in vivo.
Owner:UNIVERSITY OF PITTSBURGH

Compound feed for 0-21-days-old broiler chicken and preparation method of compound feed

The invention discloses a compound feed for 0-21-days-old broiler chicken and a preparation method of the compound feed. The compound feed is prepared from various raw materials of corn, flour, soybean meal, 60% of corn protein powder, soybean oil, limestone, calcium hydrophosphate, salt, antimicrobial peptide for the poultry, choline chloride, methionine, threonine, lysine, compound enzyme of corn and soybean meal, premixed vitamin compound, premix compound of trace elements and traditional Chinese medicine addictives. The preparation method for the compound feed comprises the following steps of: weighing all raw materials; putting the raw materials into a pulverizer to be pulverized; putting the pulverized raw materials into a mixer to be uniformly mixed; and granulating the mixed raw materials in a granulator after mixing. The compound feed has the beneficial effects that the compound feed disclosed by the invention is added with the traditional Chinese medicine addictives, so thatthe compound feed can meet the all nature requirements of the green food, diseases can be prevented, the immunity of the organism is enhanced, and the production performance of the broiler chicken can be improved so as to create favorable social value and economic benefits.
Owner:SHANDONG NEW HOPE LIUHE GROUP

Disease treatment via antimicrobial peptide inhibitors

A method of treating a disease in a subject in need thereof is disclosed. The method comprises providing to the subject a therapeutically effective amount of a compound being capable of decreasing an activity and / or level of an antimicrobial peptide (AMP) and / or AMP-like molecule, thereby treating the disease in the subject in need thereof.
Owner:HILLMAN YITZCHAK

Selectively targeted antimicrobial peptides and the use thereof

The present invention relates to targeting peptides capable of specifically binding to microbial organisms (e.g., P. aeruginosa or S. mutans), antimicrobial peptides having antimicrobial activities, and specifically / selectively targeted antimicrobial peptides (STAMPs). In addition, the present invention provides methods of selectively killing or inhibiting microbial organisms by using the peptides or compositions provided by the present invention.
Owner:C3 JIAN +1

Novel antimicrobial peptides and use thereof

InactiveUS20090312265A1Minimizing allergy developmentReduce contentAntibacterial agentsBiocideYeastMicroorganism
The invention relates to a molecule comprising at least the amino acid sequence K X K X1 X2 X K G X wherein X is any amino acid residue X1, and X2 is K or R and wherein said molecule have a length of from about 10 to about 100 amino acid residues or an analogue thereof The invention also relates to compositions comprising said molecule and use of the molecule and / or composition of the invention to combat microorganisms, such as bacteria, viruses, fungi, including yeast, and parasites.
Owner:DERMAGEN AB

Plant culture medium and module therof

The invention relates to a plant culture medium and a module thereof. The medium is characterized by comprising following raw material including 20-40 parts by weight of peat soil, 15-25 parts by weight of compost excrements of livestocks, 15-25 parts by weight of humic acid, 10-25 parts by weight of nitrogen-phosphorus-potassium mixed fertilizers, 3-15 parts by weight of expanded perlites, 3-15 parts by weight of shiitake fungus or fermented straw fine fibers, 3-10 parts by weight of amino acid, 0.1-3 parts by weight of probiotics, 0.1-3 parts by weight of protease, 0.1-3 parts by weight of marine bioactive extracts, 0.1-3 parts by weight of antimicrobial peptides, 0.1-3 parts by weight of rooting agents and 0.1-3 parts by weight of microelements. The marine bioactive extracts adopt sea algae extracts or mussel extracts. The probiotics utilize bacillus subtilis strains. The protease utilizes papain. The module is low in weight, convenient in transport, convenient in application and good in water permeability and air permeability and satisfies all kinds of nutrition needed by plants.
Owner:林志仓

Alpha helical peptides with broad spectrum antimicrobial activity that are insensitive to salt

InactiveUS7071293B1Enhanced microbialEnhanced bacterial killingPeptide/protein ingredientsPeptide sourcesMicroorganismAntimicrobial peptides
The present invention relates to the use of antimicrobial peptides in the inhibition of microbial growth and proliferation. Novel antimicrobial truncated peptides are disclosed which are based upon SMAP 29 and RCAP 18, but which contain a lesser number of amino acid residues yet still retain bactericidal activity. In addition, synthetic peptides based upon the SMAP 29 protein are disclosed which have fewer amino acid residues and include substitutions yet retain substantial activity. The invention also relates to a method of inhibiting microbial growth by administering an effective amount of a peptide in accordance with the invention, or by combining the peptides with other antimicrobial agents or antibiotics.
Owner:UNIV OF IOWA RES FOUND +1

Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags

A process was developed for expressing antimicrobial peptides in a recombinant host cell that eliminates host cell toxicity and antimicrobial peptide degradation, as well as providing a process for rapid purification. Fusion proteins comprising a periplasmic targeting signal, cleavage site, and antimicrobial peptides provide the basis for this process which produces antimicrobial peptides that may be used in antimicrobial compositions and articles.
Owner:EI DU PONT DE NEMOURS & CO

Periodic antimicrobial peptides

One embodiment of the invention comprises a method of producing periodic peptides, which can have antimicrobial uses, and further comprises the peptides themselves. A preferred method comprises the synthesis of simple periodic peptides made from polymerizing identical monomer units of four or fewer amino acids, wherein the minimum length of active peptide is 15 or 16 residues and wherein the minimum percentage of cationic residues is at least 25%.
Owner:DOW GLOBAL TECH LLC

Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest

Labeled antimicrobial peptides and method of using the same to detect a microorganism of interest. In one embodiment, the method involves adding immuno-capture beads to a sample, the immuno-capture beads including capture antibodies coupled to a paramagnetic bead, the capture antibodies being specific for the type of microorganism of interest. After mixing, the target microorganism binds to the capture antibodies. Next, the beads are collected by positioning a magnet close to the sample, and the unbound material is removed from the sample. Then, a solution containing fluorescently-labeled antimicrobial peptide is added to the sample, the labeled peptide binding in great numbers to the immuno-captured microorganism. After removing unbound peptide, the beads are suspended in solution and a magnetic probe is used to collect the beads in a small volume. With the beads thus drawn together, the solution is excited with a laser. Such excitation causes the label to fluoresce, which fluorescence is then detected.
Owner:ARCIDIACONO STEVEN MICHAEL +3

Technique for preparing antimicrobial peptide by using Bacillus subtilis

The invention discloses a technique for preparing antimicrobial peptide by using Bacillus subtilis, belonging to the technical field of bioengineering. By using Bacillus subtilis BRT39 capable of generating broad-spectrum high-efficiency antimicrobial peptide as a production strain, liquid seed preparation, fermentation liquid preparation, fermentation liquid pretreatment, antimicrobial peptide extraction and refinement, antimicrobial peptide dry powder preparation and other techniques are carried out to prepare the high-purity antimicrobial peptide finished product, wherein the activity recovery rate is up to higher than 43.5%. The invention has the advantages of simple technique, high yield of antimicrobial peptide, and high purity; the prepared antimicrobial peptide dry powder belongs to a natural antimicrobial agent and has no toxic or side effect, and thus, can be used as a food preservative, feed additive, agricultural biological control agent or animal disease preventing agent; and the antimicrobial peptide has the advantages of no toxicity, no residue, no drug resistance and high safety.
Owner:XUZHOU UNIV OF TECH

Expression of antimicrobial peptide via the plastid genome to control phytopathogenic bacteria

This invention provides a novel method to confer disease resistance to plants. Plant plastids are transformed using a plastid vector which contains heterologous DNA sequences coding for a cytotoxic antimicrobial peptide. Transgenic plants are capable of fighting off phytopathogenic bacterial infection.
Owner:UNIV OF CENT FLORIDA +1

Antimicrobial peptides with reduced hemolysis and methods of their use

The invention is directed to antimicrobial peptides related to cyclic and short peptides (less than 10 amino acid residues) with unique patterns of aromatic and cationic residues that perform a wide range of antimicrobial activities but display low hemolysis.
Owner:PACGEN BIOPHARMLS CORP

Retrocyclins: antiviral and antimicrobial peptides

Retrocyclin peptides are small antimicrobial agents with potent activity against bacteria and viruses. The peptides are nonhemolytic, and exhibit minimal in vitro cytotoxicity. A pharmaceutical composition comprising retrocyclin as an active agent is administered therapeutically to a patient suffering from a bacterial and / or viral infection, or to an individual facing exposure to a bacterial and / or viral infection, especially one caused by the HIV-1 retrovirus or other sexually-transmitted pathogens.
Owner:RGT UNIV OF CALIFORNIA

Process for providing antimicrobial surfaces

Processes for providing durable antimicrobial surfaces are disclosed that comprise treating a polymer substrate surface with formaldehyde followed by treatment with an antimicrobial peptide. Further embodiments include articles, including medical devices, characterized by a durable antimicrobial surface provided by the processes of the invention.
Owner:EI DU PONT DE NEMOURS & CO

Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension

An ophthalmic formulation for the treatment of glaucoma and intraocular pressure with a prostaglandin compound of the F-series (PGF), and particularly a prodrug form of a PGF2α analog, such as an ester, amide, or internal lactone, wherein preservative is an antimicrobial peptide, such as lactoferrin. In particularly preferred embodiments, the prostaglandin compound is a macrocyclic internal 1,15-lactone, such as the 16-aryloxy prostaglandin analogs, illustratively fluprostenol or cloprstenol.
Owner:CAYMAN CHEMICAL COMPANY

Compositions and methods to potentiate colistin activity

A pharmaceutical composition comprising an antimicrobial agent and an enhancer of an antimicrobial agent, wherein the enhancer of an antimicrobial agent is an inhibitor of gene, that by inactivating the gene product potentiates the effectiveness of the antimicrobial agent. In some embodiments, the pharmaceutical composition further comprises a pharmaceutically acceptable carrier. In some embodiments, the antimicrobial agent is an antimicrobial peptide such as a polymyxin, for example but not limited to colistin. In some embodiments of the present invention provides methods to treat and / or prevent infection of a subject with a microorganism by administering a pharmaceutical composition comprising an antimicrobial agent and an enhancer of an antimicrobial agent. In some embodiments, the present invention provides methods to inhibit growth of a microorganism by administering a pharmaceutical composition comprising an antimicrobial agent and an enhancer of an antimicrobial agent.
Owner:TRUSTEES OF BOSTON UNIV

Anti-microbial medical implants and uses thereof

A medical device or implant is disclosed. The medical device or implant comprises a body having at least one surface coated with, or including a peptide having at least 9 amino acid residues and less than 51 amino acid residues, the peptide including an amino acid sequence derived from an antimicrobial peptide.
Owner:TECHNION RES & DEV FOUND LTD

Antimicrobial Peptides and Methods of Use

Disclosed herein are novel antimicrobial peptides with useful, improved, or superior properties such as antimicrobial activity, desirable levels of hemolytic activity, and therapeutic index against a broad range of microorganisms including gram-negative and gram-positive bacteria and other organisms having a cellular or structural component of a lipid bilayer membrane. Also provided are methods of making and using such peptides to control microbial growth and in pharmaceutical compositions for treatment or prevention of infections caused by such microorganisms. Certain peptides are disclosed utilizing a structure-based rational design relating to an antimicrobial peptide, V681, with single D- / L-amino acid substitutions or charged residue substitutions in or near the center of the peptide on the nonpolar or polar face. Also disclosed are peptides with one or more amino acids in the D configuration, including peptides with all amino acids in the D configuration. Modified peptide analogs herein can demonstrate one or more properties such as improved antimicrobial activity, specificity, and resistance to degradation. Compositions disclosed herein have useful clinical potential as antibiotics including broad spectrum antibiotics.
Owner:UNIV OF COLORADO THE REGENTS OF

Process for providing antimicrobial surfaces

Processes for providing durable antimicrobial surfaces are disclosed that comprise treating a polymer substrate surface with formaldehyde followed by treatment with an antimicrobial peptide. Further embodiments include articles, including medical devices, characterized by a durable antimicrobial surface provided by the processes of the invention.
Owner:EI DU PONT DE NEMOURS & CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products